Jonathan Nicolas
Jonathan Nicolas is an expert in Nephrology at Hôpital Charles-Nicolle (France) (France). Jonathan Nicolas has authored 7 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 74 (community average: 125). How the SLR is computed.
LeadR Profile
Nephrology
Subspecialties: Critical Care
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2025 - 2026
Number : 7
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury. PMID 42873070 — continuous renal replacement therapy, mortality, kidney, respect, critical illness, therapeutics, renal replacement therapy, acute kidney injury | N Engl J Med Top journal | 2026 | 0 |
| AKI in Severe Legionnaires' Disease in Intensive Care Unit. PMID 42751414 — proteinuria, mortality, incidence, legionella, kidney, legionnaires' disease, therapeutics, intensive care units, rhabdomyolysis, prognosis | Kidney Int Rep | 2026 | 0 |
| Discrepancies between declared and real practices of continuous renal replacement therapy for septic acute kidney injury in French intensive care units. PMID 42221803 — continuous renal replacement therapy, kidney, biomarkers, diuretics, therapeutics, intensive care units, renal replacement therapy, hemodynamics, acute kidney injury, weaning | Ann Intensive Care | 2026 | 0 |
| Development and validation of an interpretable predictive machine learning model for successful weaning of continuous renal replacement therapy. PMID 41315416 — continuous renal replacement therapy, machine learning, natural science disciplines, therapeutics, learning, renal replacement therapy, weaning | Sci Rep | 2025 | 0 |
| Correspondence on "Renal replacement therapy". PMID 41273368 — critical care, therapeutics, intensive care units, renal replacement therapy | Intensive Care Med | 2025 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite Using Citrate vs Acetate based Dialysate NCT05936710 — buffers, acetates, hypotension, intensive care units, hemodynamics, dialysis solutions | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map